Anti-HIV Treatment Lowers Cardiovascular Risk
Wolters Kluwer Health: LippincottAntiretroviral medications for HIV do not seem to increase the risk of cardiovascular events, suggest a pair of studies in the July issue of AIDS. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry.